Bausch Health Plunges 10.45% Despite Strong Earnings

Generado por agente de IAAinvest Movers Radar
martes, 25 de marzo de 2025, 4:27 am ET1 min de lectura

On March 25, 2025, Bausch Health's stock price dropped by 10.45% in pre-market trading.

Bausch Health reported strong fourth-quarter earnings and revenue, with Xifaxan contributing significantly to sales growth. The company's earnings per share (EPS) for the quarter were $1.21, indicating robust financial performance.

Bausch Health has announced the conditional redemption of its outstanding 5.500% Senior Notes, a move that could impact its financial structure and investor sentiment.

Northwest & Ethical Investments L.P. significantly increased its holdings in

, reflecting confidence in the company's future prospects. Similarly, Charles Schwab Investment Management Inc. also boosted its position in the company's shares.

author avatar
Ainvest Movers Radar

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios